ORIGINAL ARTICLES
3.5.2. Codonolaside II (2)
was established as 3b,16a-dihydroxyolean-28-oic acid 28-
O-[b-d-xylopyranosyl (1!3)-b-d-xylopyranosyl (1!4)-
a-l-rhamnpyranosyl (1!2)-a-l-arabinopyranosyl] ester,
named codonolaside II.
Colorless amorphous solid, [a]2D0 ꢀ 33.3ꢂ (C, 0.300, MeOH). IR (nmax
,
cmꢀ1): 3428 (OH), 2926, 1733 (C¼O), 1633, 1384, 1043, 618. Positive
ion ESI-MS m/z: 1037 [M þ Na]þ, 471; negative ion ESI-MS m/z: 1013
[M––H]ꢀ. Negative ion HR-ESI-MS m/z: 1013.53130 [M––H]ꢀ (calcd for
C51H81O20 1013.53207). 1H NMR (600 MHz, pyridine-d5) and 13C NMR
(150 MHz, pyridine-d5) d: see Table 2.
The anti-inflammatory effect of the ethanolic root extract
of Codonopsis lanceolata was evaluated using the carra-
geenan induced hind paw edema of healthy adult albino
rats. The oral pre-treatment with 100 mg/kg of the extract
gave a mild activity (Table 3). It exhibited a significant
(p < 0.05, n ¼ 6) anti-inflammatory activity with the high-
est percentage of inhibition of 51.82% at 200 mg/kg dose
level at 3 h, while the reference acetylsalicylic acid (ASA)
exhibited an activity of 78.95% inhibition at 100 mg/kg
dose level at 3 h. The low yields of codonolaside I and II
did not permit their biological evaluation in the animal
model employed in the present study. According to the
literature (Navarro et al. 2001), some oleanane-type triter-
penoid saponins have shown anti-inflammatory activity in
vivo, so further chemical and pharmacological studies are
necessary for the correlation between the isolated saponins
and the traditional use of Codonopsis lanceolata in the
treatment of inflammatory-based diseases.
3.6. Acid hydrolysis of 1 and 2
Compound 1 (15 mg) in 3 mL of 1 M HCl (MeOH : H2O, v : v ¼ 2 : 8) was
refluxed at 100ꢂ for 6 h, and then neutralized with NH4OH. The solution
was extracted with EtOAc (1 mL ꢃ 2). The EtOAc and water layer were
evaporated in vacuo. The EtOAc layer contained the aglycone (1a) and the
water layer contained sugars. The aglycone (1a) was identified as echino-
cystic acid through comparison with its reported spectral data (Zhang et al.
1999) and by co-TLC (CHCl3––MeOH, v : v ¼ 12 : 1). Glucuronic acid, xy-
lose, rhamnose, and arabinose in the water layer were revealed by co-TLC
(EtOAc : MeOH : H2O : AcOH, v : v ¼ 15 : 5 : 3 : 3). By the same method,
compound 2 was acid-hydrolyzed and yielded xylose, rhamnose, and arabi-
nose from the water layer.
3.7. Alkaline hydrolysis of 1
Compound 1 (15 mg) in 3 mL of 1 M NaOH (MeOH : H2O, v : v ¼ 2 : 8)
was refluxed at 90ꢂ for 1.5 h, and then neutralized with 1 M HCl. The
solution was extracted with EtOAc (1 mL ꢃ 2). The EtOAc layer was eva-
porated in vacuo and afforded a prosapogenin (1b), which was identified
as 3-O-b-d-glucuronopyranosyl echinocystic acid through comparison with
its reported spectral data (Lee et al. 2002, 2005).
3. Experimental
3.8. Anti-inflammatory activity evaluation
3.1. Equipment
The carrageenan-induced rat hind paw edema was used as a model of
acute inflammation (Mascolo et al. 1997). Animals were divided into
groups of six each and pretreated as follows: control group (physiological
saline solution, 0.9%, 10 ml/kg, p.o.), acetylsalicylic acid (ASA) group
(100 mg/kg, p.o.), the roots ethanol extract of Codonopsis lanceolata
(REE) group I (200 mg/kg, p.o.), REE group II (100 mg/kg, p.o.), and
REE group III (50 mg/kg, p.o.). Sixty minutes after treatment, 1 ml of
0.1% (w/v) carrageenan (Sigma products) suspension in normal saline was
injected into the right hind paw of each rat. The linear diameter of the
injected paw was measured using a micrometer screw gauge for 4 h at
60 min interval after the administration of the phlogistic agent. The percen-
tage inhibition of the inflammation was calculated from Eq. (1)
Optical rotations were obtained on a Perkin-Elmer 241MC polarimeter. IR
spectra were recorded in KBr discs using a Bruker IFS-55 spectrometer.
NMR spectra were recorded on a Bruker ARX-600 (600 MHz) instrument
with TMS as internal standard. ESI-MS were obtained on an Angilent
LCQ mass spectrometer. For column chromatography, HPD-100 absorbent
resin (Cangzhou Bon Chemical Co. Ltd, China), silica gel (200–300 mesh,
Marine Chemical Industry Factory, Qingdao, China), ODS C18 (75 mm,
YMC Co. Ltd, Japan), Sephadex LH-20 (Merck, German) were employed
in the separations. TLC was performed with silica gel G (Marine Chemical
Industry Factory, Qingdao, China), and developed by spraying with 10%
ethanolic H2SO4 reagent followed by heating.
% Inhibition ¼ D0 ꢀ Dt=D0 ꢃ 100
ð1Þ
3.2. Plant material
where D0 is the average linear diameter of the injected paw of the control
group rats at a given time; and Dt is the average linear diameter of the
injected paw of the drug (i.e. REE or reference ASA) treated rats at the
same time (Moody et al. 2006).
The roots of Codonopsis lanceolata were collected in Liaoyang, Liaon-
ing province, China, on May 2004. The plant material was identified by
Professor Wei-Chun Wu of Shenyang Phamaceutical University, She-
nyang, China. A voucher specimen (NO. 20041007) is preserved in
School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical
University.
References
Corea G, Iorizzi M, Lanzotti V, Cammareri M, Conicella C, Laezzad C,
Bifulco M (2004) Astersedifolioside A––C, three new oleane-type sapo-
nins with antiproliferative activity. Bioorg Med Chem 12: 4909–4915.
Han CJ, Han LZ, Ye M, Li LJ, Han Y (2004a) Experimental studies on
the Anti-mutagenic effect of the total saponin of Codonopsis lanceolata.
J Environ Occup Med 21: 397–401.
Han CJ, Han Y, Li LJ, Ma L (2004b) Protective effect of ethanol sedi-
ments from Codonopsis lanceolata on alcoholic hepatic injury. J Environ
Occup Med 21: 401–402.
Han CJ, Li LJ, Piao KS, Shen YA, Piao YQ (1999) Experimental study on
antioxidation and promoting intelligence development of Codonopsis
lanceolata in old mice. Zhong Yao Cai 22: 136–139.
Han LZ, Han CJ, Ye M, Cui XS (2003) Inhibitory effects of Codonopsis
lanceolata saponins on micronuclei of bone marrow induced by cyclo-
phosphamide in mice. J Med Sci Yanbian Uni 26: 9–12.
Jiangsu New Medical College (1977) Dictionary of Chinese Materia Medica,
Shanghai: Shanghai Science and Technology Publisher, p. 195–196.
Lee KW, Jung HJ, Park HJ, Kim DG, Lee JY, Lee KT (2005) b-d-Xylo-
pyranosyl-(1!3)-b-d-Glucuronopyranosyl echinocystic acid isolated
from the roots of Codonopsis lanceolata induces caspase-dependent
apoptosis in human acute promyelocytic leukemia HL-60 cells. Biol
Pharm Bull 28: 854–859.
3.3. Animals
Animals used in this study were male Wistar rats with a weight of 150–
180 g. Animals were allowed free access to food and water, except for the
day of experiment.
3.4. Extraction and isolation
The dried underground parts (5.0 kg) of C. lanceolata were extracted twice
with hot 70% ethanol. After concentration in vacuo, the ethanol extract
(REE, 834 g) was suspended in water, and defatted with petroleum ether,
then extracted with EtOAc. The remaining aqueous solution was passed
through a HPD-100 absorbent resin column, and eluted gradiently with
ethanol-H2O. The 75% ethanol eluate fraction, in which triterpenoid sapo-
nins were enriched, was subjected to column chromatography over silica
gel, eluting gradiently with CHCl3––MeOH. The fraction eluted by
CHCl3––MeOH (85 : 15) contained 1 and 2, and was repeatedly chromato-
graphed over Sephadex LH-20, as well as octadecylsilanized (ODS) silica
gel, to yield compounds 1 (70 mg), compounds 2 (30 mg).
Lee KT, Choi J, Jun WT, Nam JH, Jung HJ, Park HJ (2002) Structure of a
new echinocystic acid bisdesmoside isolated from Codonopsis lanceolata
roots and the cytotoxic activity of prosapogenins. J Agric Food Chem
50: 4190–4193.
Navarro P, Giner RM, Recio MC, Manez S, Cerda-Nicolas M, Rios JL
(2001) In vivo anti-inflammatory activity of saponins from Bupleurum
rotundifolium. Life Sci 68: 1199–1206.
Zhang Z, Koike K, Jia Z, Nikaido T, Guo D, Zheng J (1999) Triterpenoidal
saponins acylated with two monoterpenic acids from Gleditsia sinensis.
Chem Pharm Bull 47: 388–393.
3.5. Compounds isolated
3.5.1. Codonolaside I (1)
Colorless amorphous solid, [a]2D0 ꢀ 62.0ꢂ (C, 0.685, MeOH). IR (nmax, cmꢀ1
)
3426 (OH), 2925, 1736 (ester carbonyl), 1630, 1385, 1211, 1043, 616.
Positive ion ESI-MS m/z: 1227 [M þ Na]þ, 1095 [M þ Na-xylose]þ; nega-
tive ion ESI-MS m/z: 1240 [M þ Cl]ꢀ, 471. Negative ion HR-ESI-MS m/z:
1239.55940 [M þ Cl]ꢀ (calcd for C58H92O26Cl 1239.55648). 1H NMR
(600 MHz, TMS, pyridine-d5) and 13C NMR (150 MHz, pyridine-d5) d:
see Table 1.
466
Pharmazie 62 (2007) 6